Cargando…
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
Treatments that target fundamental processes of aging are expected to delay several aging-related conditions simultaneously. Testing the efficacy of these treatments for potential anti-aging benefits will require clinical trials with endpoints that reflect the potential benefits of slowing processes...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768060/ https://www.ncbi.nlm.nih.gov/pubmed/36260264 http://dx.doi.org/10.1007/s11357-022-00671-8 |